Pre-print: Severity of Omicron variant of concern and vaccine effectiveness against symptomatic disease.SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland.Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study.Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil.Protocol: Investigating the uptake, effectiveness and safety of COVID-19 vaccines.First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis.Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic.Vaccinations, incidence of SARS-CoV-2 infections and COVID-19 hospitalisations in Scotland in the Delta era.Pre-print: Vaccine Effectiveness of Two-Dose BNT162b2 Against COVID-19 Symptomatic Infection and Severe Cases Among Adolecents.Pre-print: Waning of BNT162b2 or ChadOx1 mRNA Boosters against symptomatic infection and severe COVID-19 in Brazil and Scotland. Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II).Impact on emergency and elective hospital-based care in Scotland over the first year of the pandemic.Impact of first UK COVID-19 lockdown on hospital admissions in England, Scotland and Wales.Protocol: Common protocol for validation of the QCOVID algorithm across the four UK nations.Pre-print: Obesity is associated with reduced SARS-CoV-2 vaccine efficacy.COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2.Effectiveness of Two-Dose Pfizer-BioNTech vaccine among Adolescents in Scotland and Brazil.Second-dose Oxford-AstraZeneca and Pfizer-BioNTech vaccines and blood clotting and bleeding events in Scotland.Letter: Characterising adults in Scotland who are not vaccinated against COVID-19.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |